Biophytis S.A. (ALBPS.PA)

EUR 0.16

(-2.95%)

Operating Expenses Summary of Biophytis S.A.

  • Biophytis S.A.'s latest annual operating expenses in 2023 was 14.33 Million EUR , down -38.41% from previous year.
  • Biophytis S.A.'s latest quarterly operating expenses in 2024 Q1 was 2.19 Million EUR , down -43.78% from previous quarter.
  • Biophytis S.A. reported a annual operating expenses of 23.27 Million EUR in annual operating expenses 2022, down -13.22% from previous year.
  • Biophytis S.A. reported a annual operating expenses of 26.81 Million EUR in annual operating expenses 2021, up 92.33% from previous year.
  • Biophytis S.A. reported a quarterly operating expenses of 2.19 Million EUR for 2024 Q1, down -43.78% from previous quarter.
  • Biophytis S.A. reported a quarterly operating expenses of 3.52 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Biophytis S.A. (2023 - 2013)

Historical Annual Operating Expenses of Biophytis S.A. (2023 - 2013)

Year Operating Expenses Operating Expenses Growth
2023 14.33 Million EUR -38.41%
2022 23.27 Million EUR -13.22%
2021 26.81 Million EUR 92.33%
2020 13.94 Million EUR -11.1%
2019 15.68 Million EUR 13.14%
2018 13.86 Million EUR 39.9%
2017 9.9 Million EUR 24.77%
2016 7.94 Million EUR 156.26%
2015 3.09 Million EUR 359.78%
2014 673.97 Thousand EUR 35.25%
2013 498.32 Thousand EUR 0.0%

Peer Operating Expenses Comparison of Biophytis S.A.

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -243.141%
ABIVAX Société Anonyme 127.37 Million EUR 88.747%
Adocia SA 15.62 Million EUR 8.292%
Aelis Farma SA 18.81 Million EUR 23.838%
Advicenne S.A. 8.21 Million EUR -74.474%
genOway Société anonyme 16.73 Million EUR 14.37%
IntegraGen SA 5.35 Million EUR -167.781%
Medesis Pharma S.A. 1.56 Million EUR -816.097%
Neovacs S.A. 10.34 Million EUR -38.57%
NFL Biosciences SA 4.37 Million EUR -227.66%
Plant Advanced Technologies SA 2.76 Million EUR -418.401%
Quantum Genomics Société Anonyme 1.71 Million EUR -734.301%
Sensorion SA 27.05 Million EUR 47.02%
Theranexus Société Anonyme 3 Million EUR -376.974%
TME Pharma N.V. 5.49 Million EUR -160.742%
Valbiotis SA 9.86 Million EUR -45.233%
TheraVet SA 1.64 Million EUR -771.671%
Valerio Therapeutics Société anonyme 20.32 Million EUR 29.464%
DBV Technologies S.A. 89.4 Million EUR 83.969%
Genfit S.A. 54.8 Million EUR 73.847%
GeNeuro SA 14.35 Million EUR 0.169%
Innate Pharma S.A. 64.57 Million EUR 77.802%
Inventiva S.A. 120.18 Million EUR 88.074%
MaaT Pharma SA 21.59 Million EUR 33.637%
MedinCell S.A. 32.92 Million EUR 56.464%
Nanobiotix S.A. 58.92 Million EUR 75.677%
OSE Immunotherapeutics SA 23.58 Million EUR 39.239%
Poxel S.A. 28.76 Million EUR 50.172%
GenSight Biologics S.A. 32.66 Million EUR 56.115%
Transgene SA 31.23 Million EUR 54.106%
Valneva SE 134.92 Million EUR 89.377%